Letter Ruling 98-6: Sales of Substance for Treatment of Osteoarthritis by Massachusetts. Department of Revenue.
Letter Ruling 98-6: Sales of Substance for Treatment of Osteoarthritis
http://www.mass.gov/...ear(s)&L6=(1995-1999)+Rulings&sid=Ador&b=terminalcontent&f=dor_rul_reg_lr_lr_98_6&csid=Ador[11/3/2010 1:14:14 PM]
SEARCH
Select an area to search
Search
Home > Businesses > Help & Resources > Legal Library > Letter Rulings > Letter Rulings - By
Year(s) > (1995-1999) Rulings >
Letter Ruling 98-6: Sales of Substance for
Treatment of Osteoarthritis
February 13, 1998
 
You request a letter ruling regarding the application of the Massachusetts sales tax, G.L. c. 64H, to
sales of *************** (hereinafter “the Product”) a product described as a new treatment for pain
due to osteoarthritis of the knee.  In support of your request, you state the facts as follows:
I.  FACTS
The Product, a non-pharmacological therapy derived from natural hyaluronan, is used in the
treatment of osteoarthritis (OA).  The Product was developed to have physical properties comparable
to those of healthy joint (synovial) fluid; its goal is to supplement and restore the natural elastic and
viscous properties of the synovial joint fluid.  The Product is composed of modified hyaluronan
molecules called hylans, which are engineered to possess elasticity and viscosity comparable to
healthy young synovial fluid.
The Product is used to relieve osteoarthritic knee pain in patients who do not get adequate relief
from simple painkillers or from exercise and physical therapy.  The Product is injected directly into the
knee joint to address the pain and loss of function that drives patients to seek medical treatment.
Federal law restricts this product to sale by or on order of a physician or properly licensed
practitioner.
II.  RULING
Based on the facts as you state them, sales of the Product are exempt from sales tax as “medicine”
under G.L. c. 64H, § 6(l) when 1) prescribed by a registered physician for the treatment of
osteoarthritis and 2) purchased pursuant to that prescription.  Because the Product can only be sold
on prescription, sales of the Product by manufacturers and distributors to registered physicians,
nursing homes, hospitals or other health organizations are exempt under G.L. c. 64H, § 6(l), whether
it is dispensed by the organizations directly, or resold, provided that the requirements for sales of
prescription medicines in DOR Directive 91-5 are met.
III.  DISCUSSION
Massachusetts imposes a five percent sales tax on sales and rentals of tangible personal property
in Massachusetts by any vendor, unless otherwise exempt.  See G.L. c. 64H, § 2.  The exemptions
from the sales tax are found in section 6 of Chapter 64H.  Under G.L. c. 64H, § 6(l), sales of
“medicine...on prescription of registered physicians...”  are expressly exempt from sales tax.  In
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Department of Revenue Directive 91-5, we pointed out that although the Massachusetts tax statutes
do not define “medicine,” the Department’s interpretation of the term accords with its common
meaning, as evidenced by the definition in Webster’s New Collegiate Dictionary (1979) (medicine is
“a substance or preparation used in treating disease; . . . something that affects well-being”).  Id.,
citing Letter Ruling 88-4.
The Commissioner has previously ruled that substances used for diagnosis and not for direct
medication or treatment of patients are not exempt under this provision, even if such substances are
sold on prescription. See  Letter Rulings 88-4; 79-15.  However, the Product at issue  is used  in the
treatment of osteoarthritis to restore  the natural elastic and viscous properties of synovial joint fluid. 
Because it  is used in the treatment of a disease, we rule that the Product constitutes “medicine”
within the meaning of  G.L. c. 64H, § 6(l). Sales of the Product are exempt from sales tax  when sold
on prescription of registered physicians, and purchased pursuant to such prescription.  Moreover,
since the Product qualifies as a “prescription medicine” within the meaning of DOR Directive 91-5,
manufacturers’ and distributors’ lawful sales of the Product to registered physicians, pharmacies,
nursing homes, hospitals or other health organizations are exempt under G.L. c. 64H, § 6(l), provided
that the requirements of DOR Directive 91-5 are met.
Very truly yours,
/s/Mitchell Adams
Mitchell Adams
Commissioner of Revenue
MA:HMP:wrd
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